BISMU-KOTE- bismuth subsalicylate suspension 
Vedco, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BISMU-KOTE

Anti-Diarrheal Liquid
Palatable Oral Suspension

KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL USE ONLY

INDICATIONS:

A palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats.

CAUTION:

This product contains salicylate; do not administer with other salicylate containing products, such as aspirin.

DOSAGE AND ADMINISTRATION:

Administer orally.

Dogs and Cats: 1 to 3 tablespoonfuls every 1-3 hours.
Calves and Foals: 3 to 4 ounces every 2-3 hours.
Horses and Cattle: 6 to 10 ounces every 2-3 hours.

WARNING:

If diarrhea persists after using this product for 2 days, consult veterinarian.

image of eye clock

ACTIVE INGREDIENT:

Bismuth Subsalicylate........ 1.75% w/w
In a palatable aqueous suspension.
Flavoring and color added.

INACTIVE INGREDIENTS:

Water, Xanthan Gum, Magnesium Salicylate, Methyl Salicylate, Sodium Saccharin, Hydrochloric Acid, Methylparaben, Propylparaben, and FD&C Red #40.

SHAKE WELL BEFORE USING.
FOR ORAL USE ONLY
KEEP FROM FREEZING.

Store at room temperature not above 37°C (98.6°F).

NET CONTENTS:

1 GALLON (3.785 L)

Distributed By
VEDCO, INC.
St. Joseph, MO 64507

VINV-BSMO-KOTE

1 GALLON (3.785 L)

image of LBVEMS120_r0415

BISMU-KOTE 
bismuth subsalicylate suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:50989-501
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE17.4 g  in 1 L
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50989-501-294 in 1 CASE
13.785 L in 1 JUG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other04/09/2015
Labeler - Vedco, Inc. (021634266)
Establishment
NameAddressID/FEIBusiness Operations
First Priority Incorporated179925722manufacture, label, api manufacture

Revised: 11/2022
Document Id: b3e80de7-36a7-430d-8bfa-6cf8bc5920c5
Set id: 6f0731b9-3ac5-4aad-bb01-a0f6f4a9c18f
Version: 2
Effective Time: 20221114
 
Vedco, Inc.